Dose-dependent modeling of combinatorial drug responses stratifies patient survival and reveals therapeutic vulnerabilities in precision oncology
Kohei Ota, Takumi Ito, Hideyuki Shimizu
XACT models dose-dependent drug responses using transcriptomic data to predict patient survival and identify therapeutic vulnerabilities in cancer.
bioRxiv · Apr 21, 2026 · PreprintCancer Biology